The successful use of intravenous preparations of iron has emphasized the value of parenteral therapy in those cases of iron-deficiency anaemia which are recalcitrant to oral iron (Nissim, 1947 ; Ramsey, 1950 
The successful use of intravenous preparations of iron has emphasized the value of parenteral therapy in those cases of iron-deficiency anaemia which are recalcitrant to oral iron (Nissim, 1947 ; Ramsey, 1950) . Intravenous Although there was for long a conflict of opinion regarding the efficacy, in hypochromic anaemia, of iron given intramuscularly or subcutaneously (Stockman, 1893 ;  Morse, 1909 ; Bullock & Peters, 1911 ; Heath et al., 1932 ; Witts & Hare, 1933 ; Fowler, 1937 ; Pohle & Heath, 1939) , in recent years it seems to have been generally concluded that the administration of iron by these routes is not effective and not necessary.
Thus, while the British Pharmacopoeia (1932) A gruel and histamine test meal showed a histamine-fast achlorliydria. Peripheral blood examination showed Hb. 7 g.%, R.B.C. 4.57 million/cu.mm., M.C.H.C. of 22%. The blood film showed a hypochromic picture ; the platelets appeared normal in number and distribution. The total white count was 3,600/cu.mm., and showed a slightly increased proportion of monocytes but the absolute number per cu.mm. was within normal limits. The sternal marrow showed normoblastic erythropoiesis and sections were devoid of stainable iron.
The patient was kept under observation in bed for seventeen days, during which repeated blood examinations showed no change. At the end of this period, daily intramuscular injections of 100 mg. ferric phosphate* were commenced and continued for 10 days, the injections being given into the lateral aspect of alternate thighs. During these ten days he had considerable pain, slight swelling and tenderness at the sites of his injections. He was able to walk, but found difficulty in doing so.
Twenty-four hours after the start of the injections he developed a slight fever of 99?F to 100?F which lasted six days and on the final day of his course of treatment he had a spike of temperature of 101.4?F when it was noted that his white cell count had risen to 15,900/cu.mm. Although there was a slight reticulocyte count rise to 2% after four days, blood and marrow examination including the technique for stainable iron failed to show any significant improvement thirteen days after the start of treatment (Fig. 1). A course of intravenous saccliarated oxide of iron was then commenced. A dose of 50 mg. of this was given initially then 100 mg. on each of eleven consecutive days. There was a slight reticulocyte rise to 2% within two days and after twrelve days his general condition had greatly improved, his haemoglobin having risen to 9.4 g.%.
This improvement continued and twenty-nine days after the commencement of intravenous therapy with saccharated oxide of iron, the haemoglobin had risen to 14 g.%. This haemoglobin level was still maintained twenty days later and then sternal marrow examination revealed a normal amount of stainable iron. (Wintrobe, 1951) (1929, 1930) , would seem to be ideal as a control of parenteral iron under clinical trial since it is rapid in action, efficient and safe, as has been demonstrated by Nissim (1947) , Ramsey (1950) , and many others. 
